The Growth Investor Daily Brief
Michelle welcomes listeners to the latest episode of The Growth Investor Daily Brief, diving into recent Series C+ funding updates. The episode covers OneRail's efforts in optimizing last-mile delivery and their funding plans, as well as Tenstorrent's Series D success in the AI chip sector. Additionally, Maze Therapeutics' Series D financing and their future strategic plans are discussed. The episode wraps up with investor insights, providing listeners with essential information to stay informed about the evolving investment landscape. (0:00) Welcome to The Growth Investor Daily Brief (0:13) Series C+ funding updates: OneRail, Tenstorrent, and Maze Therapeutics (0:39) OneRail's optimization of last-mile delivery and funding plans (1:21) Tenstorrent's Series D success in the AI chip sector (2:22) Maze Therapeutics' Series D financing and future plans (5:14) Investor insights and episode wrap-up
9 episodes
Comments
0Be the first to comment
Sign up now and become a member of the The Growth Investor Daily Brief community!